Navigation Links
AmbiCom Forms Joint Alliance With E-Care Technology Corporation
Date:6/13/2011

MILPITAS, Calif., June 13, 2011 /PRNewswire/ -- AmbiCom Holdings, Inc. (OTCQB: ABHI), a leader in the development of wireless products for medical equipment suppliers, today announced that it has signed an agreement to form a joint alliance between its AmbiCom Technology, Inc. ("ATI") subsidiary and E-Care Technology Corporation, ("ECT") Taiwan. The agreement became effective May 1, 2011 and runs for a period of three years.

ECT is a leading manufacturer of infrared ear thermometers in Taiwan and also develops other medical devices such as intra-oral camera (dental camera). Under this joint alliance, ECT will develop, test and manufacture infrared ear thermometers and other medical devices as ATI private-labeled products under the brand name "E-Care USA, Inc." This agreement effectively gives AmbiCom new access to the $304 million market for wirelessly connected home health care devices.

"The joint alliance enables us to aggressively enter the home health care market with a differentiated, state-of-the-art suite of products utilizing our wireless technology platform," commented John Hwang, CEO and Chairman of AmbiCom. "As discussions with ECT progressed, it became clear that a joint alliance was more favorable to our shareholders than the previously contemplated merger, as this agreement provides AmbiCom with access to state-of-the-art medical devices and robust engineering to integrate our wireless communications components. Together, we expect to develop and introduce a superior product to US customers by the end of this year. This is another example of our solid relationships within the medical device industry, and we expect the joint alliance will allow both of our companies to leverage their core competencies cost effectively, in order to deliver this product and potential follow-on products in a timely manner."

About AmbiCom

AmbiCom is headquartered in Milpitas, California, and is a leading designer and developer of wireless products focusing on the wireless medical industry. The Company's wireless modules and devices are based on the Company's innovative application software for both Wi-Fi and Bluetooth technologies. AmbiCom is committed to wireless design and development of software and hardware, and to bringing new and innovative products to the wireless medical markets and other sectors. The Company plans to grow organically, and to augment that growth by selectively acquiring complementary products and technologies via acquisition opportunities deemed to be of strategic value.

Forward-Looking Statements

This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements including, but not limited to, our ability to maintain our website and associated computer systems, our ability generate sufficient market acceptance for our shipping products and services, our inability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in the our reports filed with the Securities and Exchange Commission, including those risks set forth in the Company's Current Report on Form 8-K filed on November 13, 2007, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward- looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact:
Dave Fore, Client Manager and Senior Research Analyst, Hayden IR: (206) 395-2711 or dave@haydenir.com


'/>"/>
SOURCE AmbiCom Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AmbiCom Retains Hayden IR to Develop Strategic Investor Relations Program
2. Major Medical Diagnostics Manufacturer Signs Agreement to Use AmbiCom Wireless Solution in Its Urinalysis Product Line
3. AmbiCom Renews and Expands Line of Credit With East West Bank
4. Allegheny General Hospital Performs First Liver Transplant
5. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
6. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
7. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
8. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
9. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
10. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
11. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  Visage Imaging Inc. ("Visage"), a wholly owned ... that the American College of Radiology (ACR) and ... Visage 7 Enterprise Imaging Platform as the new ... SIMulation (SIM). SIM is the assessment component of ... multi-faceted and fully-integrated online assessment, education and remediation ...
(Date:2/10/2016)... -- CERS ), Medivation, Inc. (NASDAQ: MDVN ... Therapeutics, Inc. (NASDAQ: CLDX ). --> CERS ... (NASDAQ: ADMS ) and Celldex Therapeutics, Inc. (NASDAQ: ... become vitally important in the development of targeted treatment therapies ... which are defined as those intended for the safe and ...
(Date:2/10/2016)... Israel , February 10, 2016 /PRNewswire/ ... leader in the field of cartilage repair, announces the ... 5, 2016. The $15 million investment was led by ... pharmaceutical manufacturer, and was joined by existing Regentis investors ... and both the Technion Research & Development Foundation and ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic ... to conduct a survey that takes a closer look at cases of TBI being ... and causes of TBI among the aging population, and identifies the challenges associated with ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed ... their network of laboratory service centers across the country. Launched in April of 2015, ... the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Club at ... the prestigious Distinguished Emerald Club of the World award, as determined by the ... of the most respected trade publications serving private clubs. , “We’d like to ...
(Date:2/10/2016)... ... 10, 2016 , ... Workrite Ergonomics, who is celebrating their 25th year of ... to being an internationally recognized leader in their industry. , "We are very proud ... President of Workrite. “Workrite recognized the importance of good ergonomics before most of ...
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. ... are delighted to welcome a new addition to their growing practice. Beginning this ... as a nurse practitioner performing cosmetic procedures including injectables, fillers and ...
Breaking Medicine News(10 mins):